Ex-pharma professional will lead DNB’s new biotech fund
DNB Asset Management is launching a new biotech fund later in April, despite the current uncertainty surrounding financial markets. Benedicte Bakke, who has spent most of her career in pharma, will be managing the fund. She tells AMWatch how a dentist ended up in asset management.
BY CAMILLA JENKEY
Log in to read our articles
Welcome to AMWatch. A part of our content is exclusive and reserved for our users.